Our findings suggest that HDAC2 is not the sole regulator of BRN3A and that additional specific interaction partners or transcriptional regulators are likely to be involved in the recruitment of HDAC2 to the BRN3A gene locus and its aberrant expression in melanoma. This evidence concerns the gene POU4F1 and melanoma.